The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
114236542 11423654 2 F 20120122 20160629 20150827 20160712 PER US-ALEXION-A201503257 ALEXION 0.00 M Y 105.60000 KG 20160712 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
114236542 11423654 1 PS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) FOUR DOSES 900MG + 300MG, QW T3-AD7698B02 125166 CONCENTRATE FOR SOLUTION FOR INFUSION /wk
114236542 11423654 2 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, SINGLE 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION QD
114236542 11423654 3 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 1200 MG, Q2W 125166 1200 MG CONCENTRATE FOR SOLUTION FOR INFUSION QOW
114236542 11423654 4 C AMOXICILLIN. AMOXICILLIN 1 Oral 500 MG, QD 0 500 MG CAPSULE QD
114236542 11423654 5 C ADDERALL AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE 1 Oral 20 MG, QD 0 20 MG CAPSULE QD
114236542 11423654 6 C ATARAX HYDROXYZINEHYDROXYZINE HYDROCHLORIDE 1 Oral 25 MG, TID, PRN 0 25 MG TABLET TID
114236542 11423654 7 C RENVELA SEVELAMER CARBONATE 1 Oral 800 MG, TID, WITH MEALS 0 800 MG TABLET TID
114236542 11423654 8 C BENADRYL DIPHENHYDRAMINE HYDROCHLORIDE 1 Oral UNK, Q6H, PRN 0 Q6H
114236542 11423654 9 C TYLENOL ACETAMINOPHEN 1 Unknown 0
114236542 11423654 10 C TYLENOL ACETAMINOPHEN 1 0
114236542 11423654 11 C ROBITUSSIN (GUAIFENESIN) GUAIFENESIN 1 Unknown 0
114236542 11423654 12 C ROBITUSSIN (GUAIFENESIN) GUAIFENESIN 1 0
114236542 11423654 13 C OSCAL CALCIUM CARBONATE 1 Oral 2500 MG, TID 0 2500 MG TID
114236542 11423654 14 C SEVELAMER SEVELAMER 1 Oral 800 MG, TID 0 800 MG TID
114236542 11423654 15 C ALBUTEROL /00139501/ ALBUTEROL 1 Unknown UNK, PRN 0 /yr
114236542 11423654 16 C OXYBUTYNIN OXYBUTYNIN 1 Oral 5 UNK, UNK 0 5 MG TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
114236542 11423654 1 Haemolytic uraemic syndrome
114236542 11423654 4 Prophylaxis
114236542 11423654 5 Attention deficit/hyperactivity disorder
114236542 11423654 6 Pruritus
114236542 11423654 7 Product used for unknown indication
114236542 11423654 8 Rash pruritic
114236542 11423654 9 Oropharyngeal pain
114236542 11423654 10 Cough
114236542 11423654 11 Cough
114236542 11423654 12 Nasal congestion
114236542 11423654 13 Hypocalcaemia
114236542 11423654 14 Hyperphosphataemia
114236542 11423654 15 Asthma
114236542 11423654 16 Urticaria

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
114236542 11423654 Complication associated with device
114236542 11423654 Epistaxis
114236542 11423654 Hypertension
114236542 11423654 Incorrect dose administered
114236542 11423654 Proteinuria

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
114236542 11423654 1 20120122 0
114236542 11423654 2 20120206 0
114236542 11423654 3 201202 0